Frequency of Macular Edema in Diabetic Retinopathy

Authors

  • Zainab Ilyas Department of Ophthalmology, Ayub Teaching Hospital, Abbottabad, Pakistan
  • Ammara Sadiq Department of Ophthalmology, Ayub Teaching Hospital, Abbottabad, Pakistan
  • Wishal Saleem Department of Ophthalmology, Ayub Teaching Hospital, Abbottabad, Pakistan
  • Danish Zafar Department of Ophthalmology, Ayub Teaching Hospital, Abbottabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i10.2296

Keywords:

Diabetic Retinopathy; Macular Edema; Diabetes Mellitus, Type 2; Optical Coherence Tomography; Visual Acuity.

Abstract

Diabetic macular edema is a major vision-threatening complication of diabetic retinopathy and may lead to significant loss of central vision. Optical coherence tomography allows objective detection of macular edema and helps identify patients who require early intervention. Objective: To determine the frequency of macular edema among patients with diabetic retinopathy and to assess its association with demographic, clinical, and ophthalmic factors. Methods: This hospital-based cross-sectional study was conducted in the Ophthalmology Unit of Ayub Teaching Hospital, Abbottabad, Pakistan, from 12 June 2025 to 12 September 2025. A total of 196 patients aged 40–80 years with type 2 diabetes mellitus and diagnosed diabetic retinopathy were enrolled using non-probability consecutive sampling. Demographic data, body mass index, duration of diabetes, HbA1c, visual acuity, diabetic retinopathy stage, and optical coherence tomography findings were recorded. Macular edema was diagnosed using OCT findings, including increased central macular thickness and macular retinal thickening. Data were analyzed using SPSS version 20. Associations were assessed using chi-square test or Fisher’s exact test, with p≤0.05 considered statistically significant. Results: The mean age of patients was 56.8 ± 9.4 years. There were 106 male patients (54.1%) and 90 female patients (45.9%). The mean duration of diabetes was 9.2 ± 4.8 years, mean HbA1c was 8.4 ± 1.3%, and mean central macular thickness was 336.4 ± 91.2 microns. Macular edema was detected in 100 patients, giving an overall frequency of 51.0%. The frequency increased with advancing diabetic retinopathy stage, from 22.0% in mild non-proliferative diabetic retinopathy to 81.3% in proliferative diabetic retinopathy. Patients with macular edema had significantly higher age, BMI, duration of diabetes, HbA1c, random blood sugar, central macular thickness, and poorer visual acuity compared with those without macular edema. Macular edema was significantly associated with increasing age, higher BMI, longer duration of diabetes, poor glycemic control, and advanced diabetic retinopathy stage, while gender and residence showed no significant association. Conclusion: Macular edema was present in approximately half of the patients with diabetic retinopathy in this tertiary-care Pakistani cohort. Older age, overweight or obesity, longer diabetes duration, poor glycemic control, and advanced diabetic retinopathy were significantly associated with macular edema. Routine OCT-based macular assessment should be prioritized in high-risk diabetic retinopathy patients to support early diagnosis and timely management.

Downloads

Download data is not yet available.
12

References

1. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-234. DOI: https://doi.org/10.1016/S0140-6736(23)01301-6

2. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580-1591. DOI: https://doi.org/10.1016/j.ophtha.2021.04.027

3. Hashemi H, Rezvan F, Pakzad R, Ansaripour A, Heydarian S, Yekta A, et al. Global and regional prevalence of diabetic retinopathy; a comprehensive systematic review and meta-analysis. Semin Ophthalmol. 2022;37(3):291-306. DOI: https://doi.org/10.1080/08820538.2021.1962920

4. Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747-754. DOI: https://doi.org/10.1001/jamaophthalmol.2023.2289

5. Tan TE, Wong TY. Diabetic retinopathy: looking forward to 2030. Front Endocrinol (Lausanne). 2023;13:1077669. DOI: https://doi.org/10.3389/fendo.2022.1077669

6. Vashist P, Senjam SS, Gupta V, Gupta N, Shamanna BR, Wadhwani M, et al. Prevalence of diabetic retinopathy in India: results from the National Survey 2015-19. Indian J Ophthalmol. 2021;69(11):3087-3094. DOI: https://doi.org/10.4103/ijo.IJO_1310_21

7. Li L, Hu L, Gao F, Shi Y, Chen C, Zhu X, et al. Prevalence and assessment of diabetic retinopathy in a densely populated suburban area of Tianjin, China: the Beichen Eye Study. PhotodiagnosisPhotodyn Ther. 2024;50:104385. DOI: https://doi.org/10.1016/j.pdpdt.2024.104385

8. Haliyur R, Marwah S, Mittal S, Stein JD, Shah AR. Demographic and metabolic risk factors associated with development of diabetic macular edema among persons with diabetes mellitus. Ophthalmol Sci. 2024;4(6):100557. DOI: https://doi.org/10.1016/j.xops.2024.100557

9. Couturier A, Wykoff CC, Lupidi M, Udaondo P, Peto T, Pintard PJ. Anatomic biomarkers as potential endpoints in diabetic macular edema: a systematic literature review with identification of macular volume as a key surrogate for visual acuity. Surv Ophthalmol. 2025;70(6):1090-1110. DOI: https://doi.org/10.1016/j.survophthal.2025.04.004

10. Jokhio AH, Talpur KI, Shujaat S, Talpur BR, Memon S. Prevalence of diabetic retinopathy in rural Pakistan: a population-based cross-sectional study. Indian J Ophthalmol. 2022;70(12):4364-4369. DOI: https://doi.org/10.4103/ijo.IJO_126_22

11. Lin Z, Wang FH, Wen L, Wang Y, Li D, Ding XX, et al. Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population. Int J Ophthalmol. 2022;15(2):320-326. DOI: https://doi.org/10.18240/ijo.2022.02.19

12. Shumye AF, Tegegne MM, Bekele MM, Woredekal AT, Eticha BL. Burden of diabetic macular oedema and its associated factors among adult patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia, 2023: multicentre cross-sectional study. BMJ Open. 2025;15(3):e088507. DOI: https://doi.org/10.1136/bmjopen-2024-088507

13. Alshehri AM, Almutairi MN, Alqahtani M, Alfakhri A. Prevalence of diabetic macular edema among type II diabetic patients in tele-screening program using OCT and fundus photos in a tertiary hospital, Riyadh, Saudi Arabia. Int J Retina Vitreous. 2025;11:124. DOI: https://doi.org/10.1186/s40942-025-00747-5

14. Shaikh DD, Kalhoro FA, Shaikh SP, Shaikh RD, Rathi R, Shaikh TA. The frequency of diabetic macular edema and its systemic risk factors: a cross-sectional study. Pak J Med Health Sci. 2022;16(2):744-749. DOI: https://doi.org/10.53350/pjmhs22162744

15. García-Ulloa AC, Pérez-Peralta L, Jaime-Casas S, Jiménez-Corona A, Rivera-De La Parra D, Graue-Hernández EO, et al. Risk factors associated with diabetic retinopathy with and without macular edema in recently diagnosed patients with type 2 diabetes. Diabetes Metab Syndr Obes. 2024;17:231-238. DOI: https://doi.org/10.2147/DMSO.S447658

16. Zhang G, Chen W, Chen H, Lin J, Cen LP, Xie P, et al. Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy. Asia Pac J Ophthalmol (Phila). 2024;13(3):100067. DOI: https://doi.org/10.1016/j.apjo.2024.100067

17. Wang Y, Lin Z, Zhai G, Ding XX, Wen L, Li D, et al. Prevalence of and risk factors for diabetic retinopathy and diabetic macular edema in patients with early- and late-onset diabetes mellitus. Ophthalmic Res. 2022;65(3):293-299. DOI: https://doi.org/10.1159/000508335

18. Sharma S, Karki P, Joshi SN, Parajuli S. Influence of glycaemic control on macular thickness in diabetic retinopathy. Endocrinol Diabetes Metab. 2022;5(1):e00308. DOI: https://doi.org/10.1002/edm2.308

19. Suzuki Y, Kiyosawa M. Relationship between diabetic nephropathy and development of diabetic macular edema in addition to diabetic retinopathy. Biomedicines. 2023;11(5):1502. DOI: https://doi.org/10.3390/biomedicines11051502

20. Cao X, Lu M, Xie RR, Song LN, Yang WL, Xin Z, et al. A high thyroid stimulating hormone level is associated with diabetic macular edema: a cross-sectional study of patients with type 2 diabetes mellitus. Endocr Connect. 2022;11(7):e220122. DOI: https://doi.org/10.1530/EC-22-0122

21. Yoon K, Kim E, Yu SY, Kim K. Clinical characteristics and long-term outcomes in diabetic macular edema patients: with or without additional injection following ranibizumab loading. Korean J Ophthalmol. 2022;36(5):398-406. DOI: https://doi.org/10.3341/kjo.2022.0086

22. Muayad J, Tukur HN, Loya A, Chauhan MZ, Hussain ZS, Lee AG, et al. Nationwide analysis of progressive kidney function decline and diabetic macular edema in type 2 diabetes. Ophthalmol Sci. 2026;6(1):100945. DOI: https://doi.org/10.1016/j.xops.2025.100945

23. Mateen M, Fatima S, Akbar B, Bajwa MS, Raza A. Association of central macular thickness with serum HbA1c levels in patients of diabetic retinopathy. Pak J Ophthalmol. 2025;41. DOI: https://doi.org/10.36351/pjo.v41i4.2171

Downloads

Published

2025-10-31

How to Cite

1.
Ilyas Z, Sadiq A, Saleem W, Zafar D. Frequency of Macular Edema in Diabetic Retinopathy. Biol Clin Sci Res J [Internet]. 2025 Oct. 31 [cited 2026 Jun. 24];6(10):91-6. Available from: https://bcsrj.com/ojs/index.php/bcsrj/article/view/2296

Issue

Section

Original Research Articles

Categories

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 > >> 

You may also start an advanced similarity search for this article.